Increased Incidence of Coronary Atherosclerosis in Type 2 Diabetes Mellitus: Mechanisms and Management
- 18 November 2003
- journal article
- review article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 139 (10) , 824-834
- https://doi.org/10.7326/0003-4819-139-10-200311180-00010
Abstract
Type 2 diabetes mellitus is a metabolic disease of carbohydrate metabolism. However, it should also be considered a vascular disease because diabetic patients have a strong predilection for atherosclerosis. With the increasing prevalence and earlier age at onset of diabetes, the projected effect of diabetes on cardiovascular health and resource utilization is sobering. The mechanisms of the high rate of atherosclerosis are multifactorial and give clinicians and researchers insights into potential preventive therapies. Effective pharmacologic and lifestyle interventions are available for primary and secondary prevention of cardiovascular complications. However, data show that these interventions continue to be underutilized. Treatment of patients with type 2 diabetes and coronary artery disease is similar to that of patients with coronary artery disease alone. However, patients with diabetes benefit more from treatments that reduce coronary artery disease risk.Keywords
This publication has 13 references indexed in Scilit:
- Acarbose Treatment and the Risk of Cardiovascular Disease and Hypertension in Patients With Impaired Glucose ToleranceJAMA, 2003
- MULTIFACTORIAL INTERVENTION AND CARDIOVASCULAR DISEASE IN PATIENTS WITH TYPE 2 DIABETESJournal of Cardiopulmonary Rehabilitation, 2003
- Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus.Circulation, 2002
- Obesity, Metabolic Syndrome, and Coronary AtherosclerosisCirculation, 2002
- Mechanisms of Increased Vascular Superoxide Production in Human Diabetes MellitusCirculation, 2002
- Ramipril and the Development of DiabetesJAMA, 2001
- Abciximab reduces mortality in diabetics following percutaneous coronary interventionJournal of the American College of Cardiology, 2000
- Glycometabolic State at Admission: Important Risk Marker of Mortality in Conventionally Treated Patients With Diabetes Mellitus and Acute Myocardial InfarctionCirculation, 1999
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Acute Hyperglycemia Attenuates Endothelium-Dependent Vasodilation in Humans In VivoCirculation, 1998